We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INDB:NASDAQIndependent Bank Corp. Analysis

Data as of 2026-06-22 - not real-time

$81.05

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is currently trading in a clear bullish technical environment. The 20‑day SMA sits above the 50‑day SMA, confirming short‑term upward momentum. RSI remains in the mid‑range, suggesting room for further upside without immediate overbought pressure. MACD shows a bullish crossover with a positive histogram, reinforcing the trend. Volume is on an increasing trajectory, adding conviction to the price action. Beta below one indicates the share moves less than the broader market, tempering systematic risk. 30‑day volatility is elevated, reflecting the sector’s inherent sensitivity.
Fundamental metrics reveal a compelling valuation case. The DCF model places fair value well above the current price, implying a double‑digit upside. PE aligns with the industry average, while forward PE is markedly lower, highlighting earnings acceleration. Revenue growth of over 50% year‑over‑year signals strong top‑line momentum. Operating margins are robust, and return on equity, though modest, is positive. The board’s recent announcement of a modest dividend introduces a nascent income component, though sustainability remains uncertain. Overall, the confluence of bullish technical signals and attractive valuation suggests a favorable risk‑adjusted entry point.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish SMA crossover
  • Positive MACD histogram
  • Increasing volume trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF indicates double‑digit upside
  • Strong revenue growth
  • Forward PE well below industry average

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Robust operating margins
  • Modest but positive ROE
  • Uncertain dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth51.60%
Profit Margin27.46%
P/E Ratio16.1
ROE7.32%
ROA1.08%
P/B Ratio1.1
Op. Cash Flow$355.0M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI55.4
Support$76.67
Resistance$84.14
MA 20$79.96
MA 50$78.87
MA 200$75.36
MACDBullish
VolumeIncreasing
Fear & Greed Index90.95

Valuation

Fair Value$183.98
Target Price$90.57
Upside/Downside11.75%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.86
Volatility21.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.